GlassScriptPhysician profile
James J Weber
NPI 1740266196
$8,679.03
in general payments reported to CMS, 2019-2025
16 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $183 · 2021: $351 · 2022: $3,201 · 2023: $4,270 · 2024: $214 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,590 · Food and Beverage: $1,827 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,590.00 |
| Food and Beverage | $1,827.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $214.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gastrogpo, LLC | $5,592.00 | 2022-2023 | |
| Boston Scientific Corporation | $1,207.20 | 2019-2023 | |
| Abbvie INC. | $468.81 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $288.00 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $274.09 | 2023-2025 | Omvoh |
| Pfizer INC. | $214.29 | 2024 | |
| Medtronic, INC. | $161.12 | 2021 | |
| Amgen INC. | $102.69 | 2022 | |
| Ironwood Pharmaceuticals, INC | $82.70 | 2019-2021 | |
| Covidien LP | $77.00 | 2019 | |
| Ethicon US, LLC | $49.80 | 2019-2020 | |
| Mauna Kea Technologies, INC. | $49.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.30 | 2019-2023 | Entyvio |
| Janssen Biotech, INC. | $41.47 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $13.87 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,232,056.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.